HAL vs ROIV · P/E 9.3, $19.05B cap vs rev $29.1M
Halliburton Company (HAL) versus Roivant Sciences Ltd (ROIV) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported ROIV revenue for 2025-03-31 was $29.1M. Net income was -$356.7M. Revenue was down 11.2% from 2024-03-31 to 2025-03-31. ROIV currently screens at market cap $7.47B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. ROIV currently screens at market cap $7.47B.
Not investment advice. Open the HAL and ROIV stock pages for the full models.
Not investment advice.